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Imaging	cellular	trafficking	processes	in	real	time	using	lysosome	
targeted	up-conversion	nanoparticles		
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*
β-NaYF4:Yb,Gd	 up-conversion	 nanoparticles,	 UCNPs,	 surface	
functionalized	 with	 suitable	 targetting	 peptides	 function	 as		
nontoxic	lysosome-specific	imaging	probes.			
The	 lysosome	 is	 the	 cellular	 digestive	 organelle	 and	 contains	
key	 acid	 hydrolase	 enzymes.
1
	 Lysosomes	 also	 participate	 in	
intracellular	 signaling,	 energy	 metabolism,	 degradation	 of	
endocytosed	 and	 intracellular	 materials,	 and	 plasma	
membrane	 repair.
1,	 2
	 Defects	 in,	 or	 alteration	 of,	 lysosomal	
structure	and	function	is	associated	with	multiple	pathologies,	
including	 inflammation,	 several	 types	 of	 cancer,	
neurodegenerative	 diseases,	 immune-deficiency	 diseases,	
pigmentation-bleeding	 disorders	 and	 specific	 lysosomal	
storage	 diseases	 such	 as	 TaySachs.
3-6
	 	 Currently,	 there	 is	 no	
direct	medical	 treatment	 to	 cure	 lysosomal	 storage	 diseases,	
and	 -	 due	 to	 their	 intrinsic	 complexity	 -	 investigations	 into	
endo-lysosomal	 activity	 present	 a	 major	 research	 challenge.
7
	
For	 this	 reason,	 lysosome	 targeted	 imaging	agents	are	crucial	
in	 real-time	 probing	 of	 this	 organelle’s	 role	 in	 intracellular	
processes.	
6,	8,	9
 
	 Though	 fluorescence	 imaging	 is	a	useful	 tool	 in	visualizing	
the	 localization,	 dynamics	 of	 specific	 biomolecules	 and	
biochemical	transformations,
10-12
	molecular	fluorescent	probes	
often	 suffer	 from	 problems	 such	 as	 interference	 from	
nonspecific	 background	emission,	 high	photo-bleaching	 rates,	
and	 cytotoxicity.	 Some	 of	 these	 problems	may	 be	 addressed	
through	 the	 development	 of	 organelle-specific	 fluorescent	
probes,	 which	 could	 also	 offer	 applications	 as	 potential	
diagnostics.
20-22
		
As	 imaging	 agents,	 quantum	 dots	 (QDs)	 offer	 bright	
photoluminescence,	 high	 quantum	 yields,	 broad	 ultraviolet	
excitation,	 and	 high	 photostability.
10,	 11
	 However,	 QDs	 are	
often	 chemically	 unstable	 and	 can	 be	 highly	 toxic.
11
	 In	 this	
context,	 lanthanide-based	 up-converting	 phosphors	 (UCPs)	
offer	some	distinct	advantages:	they	possess	narrow	emission	
bands	 that	 supress	 scattering,	 have	 tuneable	 emissions	 with	
long	luminescent	lifetime,	display	large	Stokes	and	anti-stokes	
shift.	They	are	also	chemically	and	photochemically	stable,	and	
exhibit	 low	toxicity.
12-16
	As	photon	upconversion	systems	they	
can	 be	 excited	 with	 near-infrared	 (NIR),	 which	 helps	 in	
suppressing	 interference	 from	 endogenous	 background	
fluorescence.	This	factor	along	with	their	low	scattering,	helps	
them	to	achieve	high	signal-to-noise	ratios	in	imaging.
14
		
At	 the	 same	 time,	 small	 peptides	 have	 become	 key	
components	in	the	surface	functionalization	of	nanostructures	
for	 biological	 application,	 This	 is	 due	 to	 their	 Inherent	
biocompatibility,	ease	of	 synthesis	and	diversity	of	 function
17,	
18
	 Previous	 reports	 have	 revealed	 that	 peptide-conjugated	
nanoparticles	can	be	used	to	target	subcellular	structures	and	
thus	provide	potential	application	as	drug-delivery	systems.
19-
22
	 Cell-penetrating	 peptides,	 CPPs,	 can	 cross	 the	 cellular	
membrane	and	transport	bioactive	cargoes	to	specific	cellular	
organelles	 such	 as	 nuclei,	 lysosomes	 or	 mitochondria	 in	 a	
nontoxic	and	efficient	way.
23,	24
		
	
Scheme	!.	Schematic	presentation	for	the	development	of	LTP-Conjugated	UC-NP.		
Earlier	 studies	 confirm	 that	 hexagonal	 β-phase	 NaYF4	 is	 an	
excellent	up-converting	host	material	 (λExt	=	980	nm)	and	can	
be	doped	with	Yb-Er	or	Yb-Tm	or	Y-Ho	rare-earth	 ion	couples	
for	 various	 optical	 applications.
25,	 26
	 Although,	 β-NaYF4:	
Yb,Er/Tm/Ho	 UC-NPs	 have	 been	 used	 for	 the	 detection	 of	
avidin,	 DNA	 and	 in	 imaging	 cells	 and	 tissues,	 use	 of	 such	
material	in	speciﬁc	subcellular	organelle	imaging	is	still	rare.		
Lysosome	targeting	Polypeptide	having	
sequence	MAAPGSARRP	LLLLLLLLLL
SiO2 coating
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In	 this	 study,	 we	 explored	 the	 possibility	 of	 using	 lysosomal	
targeting	peptide	(LTP),	a	C-terminal	20-residue	sequence	from	
the	 lysosome-associated	membrane	 glycoprotein,	 for	 surface	
functionalization	 of	 NaYF4:Yb,Gd	 UC-NPs	 and	 thus	 achieving	
lysosome	 specific	 imaging	 reagent	 with	 low	 cytotoxicity	 and	
high	cellular	uptake	–	Scheme	1.	The	sequence	of	LTP,	used	for	
our	studies,	is	MAAPGSARRP	LLLLLLLLLL,	where	the	N-terminal	
is	 protected	 with	 biotin	 and	 the	 C-terminal	 of	 leucine	 is	
available	for	facile	conjugation	to	the	UCNPs.
27
 	
NaYF4:Yb,Gd	 UC-NPs	 with	 uniform	 size	 were	 synthesized	 by	
hydrothermal	 reaction	 (SI).	 The	 synthesized	 nanoparticles	
were	 fully	 characterized	 by	 powder	 X-ray	 diffraction	 (XRD),	
transmission	 electron	 microscopy	 (TEM),	 Fourier	 transform	
infrared	 spectroscopy	 (FT-IR),	 and	 dynamic	 light	 scattering	
(DLS).	 Subsequently,	 following	 a	 typical	 Stöber-based	 surface	
modiﬁcation,	 primary	 amino	 groups	 were	 introduced	 onto	
their	surface,	allowing	chemical	coupling	between	the	UC-NPs	
and	LTP.		
The	 phase	 purity,	 crystallinity	 and	 composition	 of	 the	
synthesized	β-NaYF4:Yb,Gd	UCNPs	was	determined	by	powder	
XRD.	The	powder-XRD	pattern	of	the	synthesized	UC-NPs	(Fig.	
S1,	 ESI†)	 exhibits	 sharp	 diffraction	 peaks	 that	 are	 indexed	 to	
pure	 hexagonal-phase	 β-NaYF4	 (JCPDS	 No.	 0281192;	 space	
group:	 P63/m).
28
	 The	 absence	 of	 other	 phases	 indicates	 the	
high	purity	of	the	synthesized	UC-NPs,	while		the	sharpness	of	
the	 peaks	 indicates	 higher	 crystallinity	 for	 β-NaYF4:Yb,Gd	UC-
NPs.	This	lack	of	trap	sites	leads	to	high	luminescence	yields.		
 
Fig.	 1	 TEM	 images	 of	 (a)	 β-NaYF4:Yb,Gd	 NPs;	 (b)	 and	 (c)	 are	 corresponding	 SAED	
patterns	and	HRTEM	images	of	β-NaYF4:Yb,Gd	NPs;	(d)	LTP-	conjugated	β-NaYF4:Yb,Gd	
NPs;.	The	UCNPs	are	highly	crystalline	and	well-separated	even	after	LTP	conjugation.	
The	 size	 and	 morphology	 of	 the	 β-NaYF4:Yb,Gd	 UCNPs	 were	
characterized	 by	 TEM	 and	 DLS	 studies.	 Typical	 TEM	 image,	
shown	 in	 Fig.	 1a,	 reveal	 hexagonal,	 well-dispersed	 particles	
with	a	uniform	diameter	of	~22	nm.	The	selected	area	electron	
diffraction	 pattern	 (SAED)	 (Fig.	 1b)	 and	 high-resolution	 TEM	
images	 (Fig.	 1c)	 confirms	 the	 highly	 crystalline	 nature	 of	 the	
synthesized	UC-NPs.	Lattice	fringes	with	inter-planar	spacing	of	
0.3	 nm	 are	 attributed	 to	 the	 (101)	 planes	 of	 NaYF4:Yb,Gd.
29
	
Energy	 dispersive	 X-ray	 analysis	 confirms	 the	 elemental	
composition	 and	 the	 presence	 of	 Y,	 Si,	 Yb	 and	 Gd	 (Fig.	 S2,	
ESI†).	 TEM	 images	 of	 UC-NPs	 surface	 functionalized	with	 LTP	
reveal	an	 increase	 in	the	average	size	to	about	11	nm	(Figure	
2d)	 without	 any	 apparent	 change	 in	 their	 shape	 and	 size	
monodispersity	(Fig.	1d	and	Fig.	S3,	ESI†	).	
A	closer	look	at	the	DLS	data	reveals	a	distinct	increase	in	the	
hydrodynamic	 diameters	 of	 the	 particles	 from	 (29.8±2.0)	 nm	
for	NaYF4:Yb,Gd	UC-NPs	 to	 (47.5±1.5)	 nm	 for	 LTP	 conjugated	
UC-NPs.	 The	 initial	 zeta	 potential	 of	 (38±0.5)	 mV	 for	
NaYF4:Yb,Gd	 NPs	 decreases	 significantly	 to	 (-24.9±0.4)	 nm	
after	surface	functionalization	of	UC-NPs	with	LTP.	This	change	
is	attributed	to	the	pronounced	hydration	of	the	peptide	in	the	
aqueous	 phase.	 Thus,	 DLS	 measurements	 and	 TEM	
characterization	 unambiguously	 confirm	 peptide	 conjugation	
onto	the	amino-modiﬁed	NaYF4:Yb,Gd	NPs.	
The	 functional	 groups	 on	 the	 surfaces	 of	 bare	 and	 amino-
modiﬁed	 NaYF4:Yb,Gd	 NPs	 were	 confirmed	 by	 FT-IR	
spectroscopy.	The	surfaces	of	 the	bare	NPs	are	coated	with	a	
layer	of	hypermer	B246,	which	acts	as	the	surfactant	as	well	as	
the	 capping	 ligand	 during	 the	 synthesis.	 The	 stretching	
vibration	of	hydroxyl	group	of	hypermer	B246	exhibits	a	broad	
transmission	 band	 at	 around	 3250	 cm
-1
	 (Fig.	 2a).
30
	 	 FT-IR	
spectra	of	 the	amino-modiﬁed	NaYF4:Yb,Gd	NPs	 reveal	bands	
at	3434	cm
-1
	(broad)	and	1608	cm
-1
	for	N-H	stretching	and	N-H	
bending	 vibrations,	 respectively.	 The	 symmetrical	 stretching	
vibration	 of	 Si-O	 bond	 appears	 at	 1103	 cm
-1
.	Moreover,	 two	
peaks	at	2921	and	2847	cm
-1
	 are	assigned	 to	 the	asymmetric	
and	symmetric	stretching	vibrations	of	methylene	group	of	3-
aminopropyltriethoxysilane.	 For	 LTP	 conjugated	 UC-NPs,	 a	
stretching	vibration	band	at	1658	cm
-1
	(Figure	3c)	is	observed,	
this	 is	 assigned	 to	 	 –C=O	 amide	 bond	 formation	 through	 the	
reaction	between	the	amine	group	of	UC-NPs	and	the	carboxyl	
group	of	C-terminal	LTP.		
The	 upconversion	 photoluminescence	 spectra	 of	 the	
synthesized	 LTP	 conjugated	 UC-NPs	 was	 recorded	 following	
excitation	 with	 a	 980	 nm	 laser	 source	 (Fig.	 2b).	 The	 green	
emission	 band	 at	 around	 525	 -	 560	 nm	 can	 be	 assigned	 to	
electronic	transitions	from	
2
H11/2	→	
4
I15/2	and	
4
S3/2	→	
4
I15/2.		
	
Fig.	2	(a)	The	FT-IR	spectra	of	bare	NPs	(black);	silica	coated	β-NaYF4:Yb,Gd	NPs	
(red)	and	LTP	conjugated	UC-NPs	(blue).	(b)		Up	conversion	ﬂuorescence	spectra	
of	 solid	 LTP	 appended	 NaYF4:Yb,Gd	 NPs.	 Inset	 is	 the	 photograph	 of	 0.5	 wt	 %	
colloidal	solution	of	resultant	NPs	in	water,	excited	with	a	980	nm	laser.	
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While,	 the	 red	 emission	 band	 at	 around	 640	 -	 660	 nm	 is	
attributed	 to	 a	
4
F9/2	→	
4
I15/2	transition	 of	 the	 Yb
3+
	ions	 of	
NaYF4:Yb,Gd.	Here,	first	Yb
3+
	absorbs	980	nm	wavelength	light	
and	 consequently	 transfers	 this	 energy	 to	 a	 nearby	 Gd
3+
	ion,	
exciting	 Gd
3+
	to	 the	
4
I11/2	level.	 After	 that	 a	 second	 980	 nm	
photon	 from	 an	 excited	 Yb
3+
	can	 populate	 the	
4
F7/2	level	 of	
Gd
3+
,	 which	 then	 relaxes	 non-radiatively	 to	
the	
2
H11/2	and	
4
S3/2	levels.	 This	 results	 in	 green	 (520	
nm,	
2
H11/2	→	
4
I15/2;	 540	 nm,	
4
S3/2	→	
4
I15/2)	 and	 red	 (654	
nm,	
4
F9/2	→	
4
I15/2)	emissions,	respectively.
31
	
Results	 of	 our	 imaging	 studies	 reveals	 that	 bare	NaYF4:Yb,Gd	
UC-NPs	are	not	an	efficient	 imaging	 reagent	due	 to	 their	 low	
cellular	 uptake	 and	 lack	 of	 any	 organelle	 specificity.	 This	 is	
further	corroborated	by	reports	on	analogous	UC-NPs.	
32
	Given	
that	 NaYF4:Yb,Gd	 NPs	 are	 well-established	 optical	
upconversion	 systems,	 the	 suitability	 of	 the	 new	 systems	 for	
two	photon	microscopy,	TPM,	was	also	assessed	(Fig.	3).	Using	
this	 technique,	 intense	 intracellular	 emission	 signals	 were	
observed.	TPM	images	show	that	the	UC-NPs	are	taken	up	by	
cells,	displaying	bright	luminescence	within	the	cytosol,	Fig.	3a.	
An	 increase	 in	 the	 treatment	 concentration	 of	 UC-NPs	 also	
produces	a	concomitant	increase	in	intracellular	emission,	Fig.	
3b.	 	This	 is	also	evident	 in	the	 intensity	maps	generated	from	
these	 data,	 Fig.	 3c.	 The	 images	 show	 that	 luminescence	 is	
almost	 entirely	 from	 the	 cytoplasmic	 region	 with	 negligible	
emission	observed	from	the	nucleus.	The	punctuated	nature	of	
the	 images,	which	 is	observed	 in	 the	 intensity	maps	 (Fig.	3c),	
also	 indicates	 that	 the	 UC-NPs	 localize	 in	 specific	 regions	
within	 the	 cytoplasm.	 This	 was	 investigated	 in	 more	 detail	
through	co-localization	studies.		
Since	UC-NPs	are	decorated	with	 LTP,	 the	possibility	 that	 the	
nanpoparticles	 are	 delivered	 to	 lysosomes	was	 explored	with	
the	 help	 of	 Lyso	 Tracker	 Deep	 Red,	 LTDR,	 whose	 spectral	
properties	 are	 complementary	 to	 those	 of	 the	 nanoparticles;	
the	NPs	are	one-photon	excited	at	488	nm	and	their	emission	
is	collected	at	500	to	550	nm,	whereas	LTDR	is	excited	at	644	
nm	and	emits	at	655	nm(Fig.	4).		
	
Fig.	3	Optical	microscopy	 images	 showing	uptake	of	UC-NPs	 (A)	Phase	contrast	 (left),	
emission	after	two	photon	absorption	(middle),	combined	image	(right)	of	RAW	cells.	B.	
Effect	 of	 increasing	 concentration	of	UCP-NP	 treatment:	 20	µg	 (left),	 50	µg	 (middle),	
100	 µg	 (right).	 C.	 Intensity	 maps	 for	 the	 same	 concentrations	 shown	 in	 B.	 (Pseudo	
colour	has	been	employed	in	all	the	images).	λExt	=	975	nm.	
The	intensity	profile	of	the	Widefield	images	indicates	that	40	
percent	of	the	signals	of	Lyso	Tracker	Deep	Red	matches	with	
that	 of	 the	 LTP-conjugated	 UC-NPs.	 The	 calculated	 Pearson’s	
coefficient	 (82%)	 also	 supports	 the	 supposition	 that	 NPs	 are	
localized	 in	 the	 lysosomes	 of	 RAW	 cells	 (Fig.	 4).	 For	 further	
confirmation	of	 subcellular	 localization,	 similar	 co-localization	
experiments,	with	Mito	Tracker	Deep	Red	(MTDR)	and	Hoechst	
33258,	 were	 performed.	 Fig.	 S4	 and	 Fig.	 S5	 (ESI†).	 These	
studies	 confirm	 that	 the	 nanoparticles	 do	 not	 localise	 in	
mitochondria	 nor	 nuclei,	 confirming	 that	 the	 LTP	 conjugated	
NaYF4:Yb,Gd	UC-NPs	are	exclusively	lysosome	targeting.		
	Biocompatibility studies	 using	 the	 MTT	 assay	 performed	 on	
redispersed LTP	conjugated	UC-NPs	showed	that	viability	levels	
in	treated	cells	remained	stable	compared	to	a	control	group.	
Indeed,	 no	 decrease	 below	 99	 %	 was	 observed	 even	 after	
exposures	 to	 different	 concentrations	 of	 LTP	 conjugated	 UC-
NPs	 of	 up	 to	 24	 hrs	 (Fig.	 S7,	 ESI†).	 This	 confirms	 that	 the	
nanoprobes are	 fully	 biocompatible,	 making	 them	 excellent 
candidates	for	biomedical	applications.	
 
Fig.	 4	 Colocalization	 experiments	 of	 Intracellular	 localization	 of	 UC-NPs	 using	 Lyso	
Traker	probes:	Wide	field	microscopy	images	of	in	cellulo	emission	of	UC-NPs	(Panel	a)	
with	 intensity	 along	 traced	 line	 shown	 underneath.	 Emission	 from	 Lyso	 Traker	 Deep	
Red	 (Panel	 b)	 and	 intensity	 along	 the	 same	 line	 shown	 below.	 The	 overlap	 of	 the	
intensity	 is	 shown	 in	 Panel	 c.	 Panel	 c	 shows	 the	 overlap	 of	 the	 green	 and	 red	
fluorescence,	 indicating	 lysosomal	 localization	 of	 the	 UC-NPs.	 Panel	 d	 shows	 the	
Pearson	co-efficient	=	0.82.			
In	 conclusion,	 a	 two	 photon	 excitable	 composite	 nanoprobe	
has	been	developed.	To	the	best	of	our	knowledge,	this	is	the	
first	 report	 on	 surface	 modification	 of	 UC-NPs	 with	 an	
organelle	 targetting	 peptide	 to	 transform	 inorganic	
nanoparticles	into	organelle	specific	two	photon	imaging	nano-
probes.	These	lysosome	targeting	UCNPs	may	offer	application	
in	 the	 study	 of	 intracellular	 transport	 mechanisms	 and	
lysosome-based	diseases.	It	is	envisaged	that	this	approach	to	
surface	 chemistry	 can	 be	 extended	 to	 develop	 other	
subcellular	 imaging	 nanoprobes	 and	 future	 studies	 will			
extend	 the	 possibilities	 of	 using	 such	 systems	 for	 in-vivo	
imaging	technologies	which	may	provide	potential	applications	
in	areas	such	as	fluorescence-guided	surgery.	
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